nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C19—prostate cancer	0.169	0.611	CbGaD
Efavirenz—CYP3A4—prostate cancer	0.107	0.389	CbGaD
Efavirenz—CYP2C19—Nilutamide—prostate cancer	0.0278	0.0607	CbGbCtD
Efavirenz—CYP2C19—Bicalutamide—prostate cancer	0.0278	0.0607	CbGbCtD
Efavirenz—CYP2B6—Estrone—prostate cancer	0.0262	0.0572	CbGbCtD
Efavirenz—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0256	0.0558	CbGbCtD
Efavirenz—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0233	0.051	CbGbCtD
Efavirenz—CYP2C9—Nilutamide—prostate cancer	0.0231	0.0504	CbGbCtD
Efavirenz—CYP2C9—Bicalutamide—prostate cancer	0.0231	0.0504	CbGbCtD
Efavirenz—CYP2C19—Flutamide—prostate cancer	0.023	0.0503	CbGbCtD
Efavirenz—CYP1A2—Flutamide—prostate cancer	0.0212	0.0464	CbGbCtD
Efavirenz—CYP2D6—Bicalutamide—prostate cancer	0.0211	0.0461	CbGbCtD
Efavirenz—CYP2D6—Abiraterone—prostate cancer	0.0175	0.0382	CbGbCtD
Efavirenz—CYP1A2—Estrone—prostate cancer	0.0153	0.0335	CbGbCtD
Efavirenz—CYP2C9—Estrone—prostate cancer	0.0138	0.0302	CbGbCtD
Efavirenz—CYP3A4—Bicalutamide—prostate cancer	0.0134	0.0293	CbGbCtD
Efavirenz—CYP3A4—Estramustine—prostate cancer	0.0125	0.0273	CbGbCtD
Efavirenz—CYP3A4—Abiraterone—prostate cancer	0.0111	0.0243	CbGbCtD
Efavirenz—CYP3A4—Flutamide—prostate cancer	0.0111	0.0243	CbGbCtD
Efavirenz—CYP2C9—Capecitabine—prostate cancer	0.0105	0.0229	CbGbCtD
Efavirenz—CYP1A2—Conjugated Estrogens—prostate cancer	0.01	0.0219	CbGbCtD
Efavirenz—CYP2C19—Estradiol—prostate cancer	0.00955	0.0209	CbGbCtD
Efavirenz—CYP1A2—Estradiol—prostate cancer	0.00882	0.0193	CbGbCtD
Efavirenz—CYP3A4—Cabazitaxel—prostate cancer	0.00823	0.018	CbGbCtD
Efavirenz—CYP2C19—Prednisone—prostate cancer	0.00822	0.018	CbGbCtD
Efavirenz—CYP3A4—Estrone—prostate cancer	0.00804	0.0176	CbGbCtD
Efavirenz—CYP2C9—Estradiol—prostate cancer	0.00794	0.0174	CbGbCtD
Efavirenz—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00717	0.0157	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—prostate cancer	0.0067	0.0146	CbGbCtD
Efavirenz—CYP1A2—Etoposide—prostate cancer	0.00576	0.0126	CbGbCtD
Efavirenz—CYP3A4—Conjugated Estrogens—prostate cancer	0.00526	0.0115	CbGbCtD
Efavirenz—CYP3A4—Mitoxantrone—prostate cancer	0.00478	0.0105	CbGbCtD
Efavirenz—CYP3A4—Estradiol—prostate cancer	0.00462	0.0101	CbGbCtD
Efavirenz—CYP3A4—Prednisone—prostate cancer	0.00397	0.00868	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—prostate cancer	0.00323	0.00707	CbGbCtD
Efavirenz—CYP3A4—Etoposide—prostate cancer	0.00302	0.00659	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—prostate cancer	0.00276	0.00603	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—prostate cancer	0.00206	0.00449	CbGbCtD
Efavirenz—CYP2C19—urine—prostate cancer	0.00104	0.215	CbGeAlD
Efavirenz—CYP1A2—urine—prostate cancer	0.000852	0.175	CbGeAlD
Efavirenz—CYP2C9—urine—prostate cancer	0.000809	0.166	CbGeAlD
Efavirenz—CYP3A4—urine—prostate cancer	0.000617	0.127	CbGeAlD
Efavirenz—CYP2D6—urine—prostate cancer	0.000607	0.125	CbGeAlD
Efavirenz—CYP1A2—renal system—prostate cancer	0.000208	0.0429	CbGeAlD
Efavirenz—CYP2B6—renal system—prostate cancer	0.0002	0.0411	CbGeAlD
Efavirenz—CYP3A4—renal system—prostate cancer	0.000151	0.031	CbGeAlD
Efavirenz—CYP2D6—renal system—prostate cancer	0.000148	0.0305	CbGeAlD
Efavirenz—CYP2B6—testis—prostate cancer	0.000129	0.0266	CbGeAlD
Efavirenz—CYP2D6—testis—prostate cancer	9.6e-05	0.0197	CbGeAlD
Efavirenz—Vomiting—Mitoxantrone—prostate cancer	3.18e-05	0.000186	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—prostate cancer	3.18e-05	0.000186	CcSEcCtD
Efavirenz—Convulsion—Prednisone—prostate cancer	3.17e-05	0.000185	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—prostate cancer	3.16e-05	0.000185	CcSEcCtD
Efavirenz—Hypertension—Prednisone—prostate cancer	3.16e-05	0.000185	CcSEcCtD
Efavirenz—Rash—Mitoxantrone—prostate cancer	3.15e-05	0.000185	CcSEcCtD
Efavirenz—Dermatitis—Mitoxantrone—prostate cancer	3.15e-05	0.000184	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.15e-05	0.000184	CcSEcCtD
Efavirenz—Headache—Mitoxantrone—prostate cancer	3.13e-05	0.000183	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—prostate cancer	3.13e-05	0.000183	CcSEcCtD
Efavirenz—Arthralgia—Prednisone—prostate cancer	3.11e-05	0.000182	CcSEcCtD
Efavirenz—Myalgia—Prednisone—prostate cancer	3.11e-05	0.000182	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—prostate cancer	3.11e-05	0.000182	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—prostate cancer	3.1e-05	0.000182	CcSEcCtD
Efavirenz—Anxiety—Prednisone—prostate cancer	3.1e-05	0.000182	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.09e-05	0.000181	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—prostate cancer	3.08e-05	0.00018	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—prostate cancer	3.07e-05	0.00018	CcSEcCtD
Efavirenz—Discomfort—Prednisone—prostate cancer	3.07e-05	0.00018	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—prostate cancer	3.07e-05	0.00018	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—prostate cancer	3.07e-05	0.000179	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—prostate cancer	3.06e-05	0.000179	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.05e-05	0.000179	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—prostate cancer	3.05e-05	0.000178	CcSEcCtD
Efavirenz—Flushing—Epirubicin—prostate cancer	3.05e-05	0.000178	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—prostate cancer	3.05e-05	0.000178	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—prostate cancer	3.04e-05	0.000178	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—prostate cancer	3.04e-05	0.000178	CcSEcCtD
Efavirenz—Insomnia—Capecitabine—prostate cancer	3.03e-05	0.000177	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—prostate cancer	3.02e-05	0.000177	CcSEcCtD
Efavirenz—Paraesthesia—Capecitabine—prostate cancer	3.01e-05	0.000176	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—prostate cancer	3.01e-05	0.000176	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—prostate cancer	3e-05	0.000176	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—prostate cancer	2.99e-05	0.000175	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—prostate cancer	2.99e-05	0.000175	CcSEcCtD
Efavirenz—Asthenia—Etoposide—prostate cancer	2.99e-05	0.000175	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—prostate cancer	2.99e-05	0.000175	CcSEcCtD
Efavirenz—Dyspnoea—Capecitabine—prostate cancer	2.99e-05	0.000175	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—prostate cancer	2.98e-05	0.000175	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—prostate cancer	2.98e-05	0.000174	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—prostate cancer	2.98e-05	0.000174	CcSEcCtD
Efavirenz—Nausea—Mitoxantrone—prostate cancer	2.97e-05	0.000174	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—prostate cancer	2.97e-05	0.000174	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—prostate cancer	2.96e-05	0.000173	CcSEcCtD
Efavirenz—Pain—Docetaxel—prostate cancer	2.96e-05	0.000173	CcSEcCtD
Efavirenz—Constipation—Docetaxel—prostate cancer	2.96e-05	0.000173	CcSEcCtD
Efavirenz—Dyspepsia—Capecitabine—prostate cancer	2.95e-05	0.000173	CcSEcCtD
Efavirenz—Pruritus—Etoposide—prostate cancer	2.94e-05	0.000172	CcSEcCtD
Efavirenz—Shock—Prednisone—prostate cancer	2.93e-05	0.000172	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—prostate cancer	2.93e-05	0.000172	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—prostate cancer	2.93e-05	0.000171	CcSEcCtD
Efavirenz—Nervous system disorder—Prednisone—prostate cancer	2.93e-05	0.000171	CcSEcCtD
Efavirenz—Tachycardia—Prednisone—prostate cancer	2.91e-05	0.00017	CcSEcCtD
Efavirenz—Decreased appetite—Capecitabine—prostate cancer	2.91e-05	0.00017	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—prostate cancer	2.9e-05	0.00017	CcSEcCtD
Efavirenz—Skin disorder—Prednisone—prostate cancer	2.9e-05	0.00017	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Capecitabine—prostate cancer	2.89e-05	0.000169	CcSEcCtD
Efavirenz—Fatigue—Capecitabine—prostate cancer	2.89e-05	0.000169	CcSEcCtD
Efavirenz—Hyperhidrosis—Prednisone—prostate cancer	2.88e-05	0.000169	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—prostate cancer	2.87e-05	0.000168	CcSEcCtD
Efavirenz—Constipation—Capecitabine—prostate cancer	2.86e-05	0.000168	CcSEcCtD
Efavirenz—Pain—Capecitabine—prostate cancer	2.86e-05	0.000168	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—prostate cancer	2.86e-05	0.000167	CcSEcCtD
Efavirenz—Erythema—Epirubicin—prostate cancer	2.86e-05	0.000167	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—prostate cancer	2.85e-05	0.000167	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—prostate cancer	2.85e-05	0.000167	CcSEcCtD
Efavirenz—Anorexia—Prednisone—prostate cancer	2.84e-05	0.000166	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—prostate cancer	2.84e-05	0.000166	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—prostate cancer	2.83e-05	0.000166	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—prostate cancer	2.83e-05	0.000166	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—prostate cancer	2.82e-05	0.000165	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—prostate cancer	2.82e-05	0.000165	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—prostate cancer	2.82e-05	0.000165	CcSEcCtD
Efavirenz—Tension—Epirubicin—prostate cancer	2.81e-05	0.000164	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—prostate cancer	2.8e-05	0.000164	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—prostate cancer	2.78e-05	0.000163	CcSEcCtD
Efavirenz—Back pain—Epirubicin—prostate cancer	2.77e-05	0.000162	CcSEcCtD
Efavirenz—Feeling abnormal—Capecitabine—prostate cancer	2.76e-05	0.000162	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—prostate cancer	2.76e-05	0.000161	CcSEcCtD
Efavirenz—Dizziness—Etoposide—prostate cancer	2.75e-05	0.000161	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—prostate cancer	2.74e-05	0.000161	CcSEcCtD
Efavirenz—Gastrointestinal pain—Capecitabine—prostate cancer	2.74e-05	0.00016	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—prostate cancer	2.74e-05	0.00016	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—prostate cancer	2.73e-05	0.00016	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—prostate cancer	2.73e-05	0.00016	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Prednisone—prostate cancer	2.72e-05	0.000159	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—prostate cancer	2.71e-05	0.000159	CcSEcCtD
Efavirenz—Insomnia—Prednisone—prostate cancer	2.7e-05	0.000158	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—prostate cancer	2.69e-05	0.000158	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—prostate cancer	2.68e-05	0.000157	CcSEcCtD
Efavirenz—Paraesthesia—Prednisone—prostate cancer	2.68e-05	0.000157	CcSEcCtD
Efavirenz—Urticaria—Capecitabine—prostate cancer	2.66e-05	0.000156	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—prostate cancer	2.65e-05	0.000155	CcSEcCtD
Efavirenz—Abdominal pain—Capecitabine—prostate cancer	2.65e-05	0.000155	CcSEcCtD
Efavirenz—Body temperature increased—Capecitabine—prostate cancer	2.65e-05	0.000155	CcSEcCtD
Efavirenz—Vomiting—Etoposide—prostate cancer	2.65e-05	0.000155	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—prostate cancer	2.64e-05	0.000155	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—prostate cancer	2.64e-05	0.000155	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—prostate cancer	2.64e-05	0.000155	CcSEcCtD
Efavirenz—Agitation—Epirubicin—prostate cancer	2.63e-05	0.000154	CcSEcCtD
Efavirenz—Dyspepsia—Prednisone—prostate cancer	2.63e-05	0.000154	CcSEcCtD
Efavirenz—Rash—Etoposide—prostate cancer	2.62e-05	0.000154	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—prostate cancer	2.62e-05	0.000153	CcSEcCtD
Efavirenz—Headache—Etoposide—prostate cancer	2.61e-05	0.000153	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—prostate cancer	2.61e-05	0.000153	CcSEcCtD
Efavirenz—Tension—Doxorubicin—prostate cancer	2.6e-05	0.000152	CcSEcCtD
Efavirenz—Decreased appetite—Prednisone—prostate cancer	2.59e-05	0.000152	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—prostate cancer	2.59e-05	0.000152	CcSEcCtD
Efavirenz—Malaise—Epirubicin—prostate cancer	2.58e-05	0.000151	CcSEcCtD
Efavirenz—Fatigue—Prednisone—prostate cancer	2.57e-05	0.000151	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—prostate cancer	2.57e-05	0.00015	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—prostate cancer	2.57e-05	0.00015	CcSEcCtD
Efavirenz—Syncope—Epirubicin—prostate cancer	2.56e-05	0.00015	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—prostate cancer	2.56e-05	0.00015	CcSEcCtD
Efavirenz—Constipation—Prednisone—prostate cancer	2.55e-05	0.000149	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—prostate cancer	2.55e-05	0.000149	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—prostate cancer	2.53e-05	0.000148	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—prostate cancer	2.51e-05	0.000147	CcSEcCtD
Efavirenz—Cough—Epirubicin—prostate cancer	2.49e-05	0.000146	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—prostate cancer	2.49e-05	0.000146	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—prostate cancer	2.48e-05	0.000145	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—prostate cancer	2.48e-05	0.000145	CcSEcCtD
Efavirenz—Nausea—Etoposide—prostate cancer	2.47e-05	0.000145	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—prostate cancer	2.47e-05	0.000144	CcSEcCtD
Efavirenz—Hypersensitivity—Capecitabine—prostate cancer	2.47e-05	0.000144	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisone—prostate cancer	2.46e-05	0.000144	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—prostate cancer	2.45e-05	0.000144	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—prostate cancer	2.45e-05	0.000143	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—prostate cancer	2.44e-05	0.000143	CcSEcCtD
Efavirenz—Gastrointestinal pain—Prednisone—prostate cancer	2.44e-05	0.000143	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—prostate cancer	2.43e-05	0.000142	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.42e-05	0.000141	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—prostate cancer	2.4e-05	0.000141	CcSEcCtD
Efavirenz—Asthenia—Capecitabine—prostate cancer	2.4e-05	0.000141	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—prostate cancer	2.39e-05	0.00014	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—prostate cancer	2.38e-05	0.000139	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—prostate cancer	2.38e-05	0.000139	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—prostate cancer	2.37e-05	0.000139	CcSEcCtD
Efavirenz—Urticaria—Prednisone—prostate cancer	2.37e-05	0.000139	CcSEcCtD
Efavirenz—Pruritus—Capecitabine—prostate cancer	2.37e-05	0.000139	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—prostate cancer	2.37e-05	0.000139	CcSEcCtD
Efavirenz—Body temperature increased—Prednisone—prostate cancer	2.36e-05	0.000138	CcSEcCtD
Efavirenz—Abdominal pain—Prednisone—prostate cancer	2.36e-05	0.000138	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—prostate cancer	2.35e-05	0.000138	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—prostate cancer	2.34e-05	0.000137	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—prostate cancer	2.32e-05	0.000136	CcSEcCtD
Efavirenz—Cough—Doxorubicin—prostate cancer	2.31e-05	0.000135	CcSEcCtD
Efavirenz—Shock—Epirubicin—prostate cancer	2.3e-05	0.000134	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—prostate cancer	2.29e-05	0.000134	CcSEcCtD
Efavirenz—Diarrhoea—Capecitabine—prostate cancer	2.29e-05	0.000134	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—prostate cancer	2.29e-05	0.000134	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—prostate cancer	2.29e-05	0.000134	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—prostate cancer	2.28e-05	0.000134	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—prostate cancer	2.28e-05	0.000134	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—prostate cancer	2.28e-05	0.000133	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—prostate cancer	2.27e-05	0.000133	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—prostate cancer	2.26e-05	0.000132	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—prostate cancer	2.25e-05	0.000132	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—prostate cancer	2.25e-05	0.000132	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—prostate cancer	2.25e-05	0.000132	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—prostate cancer	2.24e-05	0.000131	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.24e-05	0.000131	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—prostate cancer	2.22e-05	0.00013	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—prostate cancer	2.22e-05	0.00013	CcSEcCtD
Efavirenz—Dizziness—Capecitabine—prostate cancer	2.21e-05	0.00013	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—prostate cancer	2.2e-05	0.000129	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—prostate cancer	2.2e-05	0.000129	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisone—prostate cancer	2.2e-05	0.000129	CcSEcCtD
Efavirenz—Rash—Docetaxel—prostate cancer	2.18e-05	0.000128	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—prostate cancer	2.18e-05	0.000128	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—prostate cancer	2.18e-05	0.000127	CcSEcCtD
Efavirenz—Headache—Docetaxel—prostate cancer	2.17e-05	0.000127	CcSEcCtD
Efavirenz—Asthenia—Prednisone—prostate cancer	2.14e-05	0.000125	CcSEcCtD
Efavirenz—Vomiting—Capecitabine—prostate cancer	2.13e-05	0.000125	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.13e-05	0.000124	CcSEcCtD
Efavirenz—Shock—Doxorubicin—prostate cancer	2.12e-05	0.000124	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—prostate cancer	2.12e-05	0.000124	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—prostate cancer	2.11e-05	0.000124	CcSEcCtD
Efavirenz—Rash—Capecitabine—prostate cancer	2.11e-05	0.000124	CcSEcCtD
Efavirenz—Pruritus—Prednisone—prostate cancer	2.11e-05	0.000124	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—prostate cancer	2.11e-05	0.000124	CcSEcCtD
Efavirenz—Dermatitis—Capecitabine—prostate cancer	2.11e-05	0.000123	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—prostate cancer	2.11e-05	0.000123	CcSEcCtD
Efavirenz—Headache—Capecitabine—prostate cancer	2.1e-05	0.000123	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—prostate cancer	2.1e-05	0.000123	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—prostate cancer	2.09e-05	0.000123	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—prostate cancer	2.09e-05	0.000122	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—prostate cancer	2.08e-05	0.000122	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—prostate cancer	2.07e-05	0.000121	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—prostate cancer	2.06e-05	0.00012	CcSEcCtD
Efavirenz—Nausea—Docetaxel—prostate cancer	2.05e-05	0.00012	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—prostate cancer	2.05e-05	0.00012	CcSEcCtD
Efavirenz—Diarrhoea—Prednisone—prostate cancer	2.04e-05	0.000119	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—prostate cancer	2.03e-05	0.000119	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—prostate cancer	2.01e-05	0.000118	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—prostate cancer	2.01e-05	0.000118	CcSEcCtD
Efavirenz—Pain—Epirubicin—prostate cancer	2e-05	0.000117	CcSEcCtD
Efavirenz—Constipation—Epirubicin—prostate cancer	2e-05	0.000117	CcSEcCtD
Efavirenz—Nausea—Capecitabine—prostate cancer	1.99e-05	0.000116	CcSEcCtD
Efavirenz—Dizziness—Prednisone—prostate cancer	1.97e-05	0.000115	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.97e-05	0.000115	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—prostate cancer	1.95e-05	0.000114	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—prostate cancer	1.94e-05	0.000113	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—prostate cancer	1.92e-05	0.000113	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—prostate cancer	1.92e-05	0.000113	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—prostate cancer	1.92e-05	0.000112	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—prostate cancer	1.91e-05	0.000112	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—prostate cancer	1.9e-05	0.000111	CcSEcCtD
Efavirenz—Vomiting—Prednisone—prostate cancer	1.9e-05	0.000111	CcSEcCtD
Efavirenz—Rash—Prednisone—prostate cancer	1.88e-05	0.00011	CcSEcCtD
Efavirenz—Dermatitis—Prednisone—prostate cancer	1.88e-05	0.00011	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—prostate cancer	1.88e-05	0.00011	CcSEcCtD
Efavirenz—Headache—Prednisone—prostate cancer	1.87e-05	0.000109	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.86e-05	0.000109	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—prostate cancer	1.86e-05	0.000109	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—prostate cancer	1.85e-05	0.000108	CcSEcCtD
Efavirenz—Pain—Doxorubicin—prostate cancer	1.85e-05	0.000108	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—prostate cancer	1.85e-05	0.000108	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—prostate cancer	1.84e-05	0.000108	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—prostate cancer	1.84e-05	0.000108	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—prostate cancer	1.78e-05	0.000104	CcSEcCtD
Efavirenz—Nausea—Prednisone—prostate cancer	1.77e-05	0.000104	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—prostate cancer	1.77e-05	0.000103	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—prostate cancer	1.72e-05	0.000101	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—prostate cancer	1.71e-05	0.0001	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—prostate cancer	1.71e-05	9.99e-05	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—prostate cancer	1.71e-05	9.99e-05	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—prostate cancer	1.67e-05	9.8e-05	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—prostate cancer	1.65e-05	9.66e-05	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—prostate cancer	1.6e-05	9.34e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—prostate cancer	1.59e-05	9.31e-05	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—prostate cancer	1.55e-05	9.07e-05	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—prostate cancer	1.54e-05	9.03e-05	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—prostate cancer	1.53e-05	8.94e-05	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—prostate cancer	1.48e-05	8.68e-05	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—prostate cancer	1.48e-05	8.65e-05	CcSEcCtD
Efavirenz—Rash—Epirubicin—prostate cancer	1.47e-05	8.61e-05	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—prostate cancer	1.47e-05	8.6e-05	CcSEcCtD
Efavirenz—Headache—Epirubicin—prostate cancer	1.46e-05	8.55e-05	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—prostate cancer	1.43e-05	8.36e-05	CcSEcCtD
Efavirenz—Nausea—Epirubicin—prostate cancer	1.39e-05	8.11e-05	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—prostate cancer	1.37e-05	8.03e-05	CcSEcCtD
Efavirenz—Rash—Doxorubicin—prostate cancer	1.36e-05	7.97e-05	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—prostate cancer	1.36e-05	7.96e-05	CcSEcCtD
Efavirenz—Headache—Doxorubicin—prostate cancer	1.35e-05	7.92e-05	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—prostate cancer	1.28e-05	7.51e-05	CcSEcCtD
Efavirenz—CYP2C19—Metabolism—NCOA2—prostate cancer	4.44e-06	4.92e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2A6—prostate cancer	4.43e-06	4.92e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.42e-06	4.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SULT2A1—prostate cancer	4.41e-06	4.89e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKR1C3—prostate cancer	4.35e-06	4.83e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MED12—prostate cancer	4.33e-06	4.81e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PRKACB—prostate cancer	4.33e-06	4.8e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKR1C3—prostate cancer	4.31e-06	4.78e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GNG5—prostate cancer	4.3e-06	4.77e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PRKACB—prostate cancer	4.29e-06	4.76e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP17A1—prostate cancer	4.28e-06	4.75e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.28e-06	4.75e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.28e-06	4.75e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.25e-06	4.71e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.23e-06	4.7e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TYMS—prostate cancer	4.19e-06	4.65e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.19e-06	4.65e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—prostate cancer	4.15e-06	4.6e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA3—prostate cancer	4.14e-06	4.6e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.13e-06	4.59e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.1e-06	4.55e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA4—prostate cancer	4.1e-06	4.55e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NQO1—prostate cancer	4.09e-06	4.54e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOA2—prostate cancer	4.08e-06	4.53e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.07e-06	4.52e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—LPL—prostate cancer	4.07e-06	4.52e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOA2—prostate cancer	4.05e-06	4.49e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TH—prostate cancer	4.03e-06	4.47e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4e-06	4.44e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA2—prostate cancer	4e-06	4.44e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.99e-06	4.42e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.97e-06	4.4e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HPGDS—prostate cancer	3.95e-06	4.38e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG5—prostate cancer	3.95e-06	4.38e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.95e-06	4.38e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1A1—prostate cancer	3.93e-06	4.36e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.93e-06	4.36e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.92e-06	4.35e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ERCC2—prostate cancer	3.9e-06	4.32e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.89e-06	4.32e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.86e-06	4.28e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA1—prostate cancer	3.86e-06	4.28e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ACHE—prostate cancer	3.83e-06	4.25e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—prostate cancer	3.83e-06	4.25e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NAT2—prostate cancer	3.81e-06	4.23e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.81e-06	4.23e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTO1—prostate cancer	3.81e-06	4.23e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.8e-06	4.22e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GGT1—prostate cancer	3.8e-06	4.21e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.79e-06	4.2e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.77e-06	4.19e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.77e-06	4.18e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NQO1—prostate cancer	3.76e-06	4.17e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOA1—prostate cancer	3.74e-06	4.15e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NQO1—prostate cancer	3.73e-06	4.14e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TH—prostate cancer	3.71e-06	4.11e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.69e-06	4.09e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.68e-06	4.09e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TH—prostate cancer	3.67e-06	4.08e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.67e-06	4.07e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PRKACB—prostate cancer	3.67e-06	4.07e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—prostate cancer	3.66e-06	4.07e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLCB2—prostate cancer	3.66e-06	4.06e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LRP2—prostate cancer	3.66e-06	4.06e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.66e-06	4.06e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.65e-06	4.05e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.63e-06	4.03e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.63e-06	4.03e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.62e-06	4.01e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.6e-06	4e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARA—prostate cancer	3.59e-06	3.99e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—P4HB—prostate cancer	3.59e-06	3.98e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.58e-06	3.97e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.57e-06	3.96e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—RXRA—prostate cancer	3.56e-06	3.95e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GGT1—prostate cancer	3.49e-06	3.87e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.49e-06	3.87e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GGT1—prostate cancer	3.46e-06	3.84e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.46e-06	3.84e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA2—prostate cancer	3.46e-06	3.84e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOA1—prostate cancer	3.44e-06	3.82e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—COMT—prostate cancer	3.43e-06	3.8e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—prostate cancer	3.41e-06	3.78e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOA1—prostate cancer	3.41e-06	3.78e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.4e-06	3.77e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.39e-06	3.76e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAV1—prostate cancer	3.38e-06	3.75e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.36e-06	3.73e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ITPR1—prostate cancer	3.35e-06	3.72e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MED12—prostate cancer	3.34e-06	3.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GNG5—prostate cancer	3.32e-06	3.68e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.3e-06	3.66e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.3e-06	3.66e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—RXRA—prostate cancer	3.27e-06	3.63e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—RXRA—prostate cancer	3.24e-06	3.6e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.22e-06	3.57e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA3—prostate cancer	3.2e-06	3.55e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NQO1—prostate cancer	3.18e-06	3.53e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TYMS—prostate cancer	3.17e-06	3.52e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.15e-06	3.5e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—COMT—prostate cancer	3.15e-06	3.5e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TH—prostate cancer	3.14e-06	3.48e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—prostate cancer	3.14e-06	3.48e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—prostate cancer	3.13e-06	3.48e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—COMT—prostate cancer	3.12e-06	3.47e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.12e-06	3.46e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—prostate cancer	3.11e-06	3.45e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.11e-06	3.45e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.09e-06	3.43e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ITPR1—prostate cancer	3.09e-06	3.42e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—prostate cancer	3.08e-06	3.42e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LPL—prostate cancer	3.08e-06	3.41e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ITPR1—prostate cancer	3.06e-06	3.39e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.05e-06	3.39e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HPGDS—prostate cancer	3.05e-06	3.38e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.03e-06	3.36e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.01e-06	3.34e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.97e-06	3.3e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—prostate cancer	2.96e-06	3.28e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ACHE—prostate cancer	2.96e-06	3.28e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GGT1—prostate cancer	2.96e-06	3.28e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ERCC2—prostate cancer	2.95e-06	3.27e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.92e-06	3.24e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TYMS—prostate cancer	2.92e-06	3.23e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—INS—prostate cancer	2.91e-06	3.23e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA1—prostate cancer	2.91e-06	3.23e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TYMS—prostate cancer	2.89e-06	3.21e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—prostate cancer	2.88e-06	3.2e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.87e-06	3.19e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—prostate cancer	2.86e-06	3.17e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CREBBP—prostate cancer	2.85e-06	3.17e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.84e-06	3.16e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PRKACB—prostate cancer	2.83e-06	3.14e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LPL—prostate cancer	2.83e-06	3.14e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LPL—prostate cancer	2.8e-06	3.11e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.8e-06	3.11e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—RXRA—prostate cancer	2.77e-06	3.07e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—prostate cancer	2.77e-06	3.07e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.73e-06	3.03e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARA—prostate cancer	2.72e-06	3.01e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ERCC2—prostate cancer	2.71e-06	3.01e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.71e-06	3e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.71e-06	3e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.69e-06	2.99e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ERCC2—prostate cancer	2.69e-06	2.98e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—COMT—prostate cancer	2.67e-06	2.96e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA2—prostate cancer	2.67e-06	2.96e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—prostate cancer	2.66e-06	2.95e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ITPR1—prostate cancer	2.61e-06	2.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.57e-06	2.85e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NOS3—prostate cancer	2.56e-06	2.84e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAV1—prostate cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—prostate cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.55e-06	2.82e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—prostate cancer	2.52e-06	2.8e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARA—prostate cancer	2.5e-06	2.77e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.49e-06	2.76e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARA—prostate cancer	2.48e-06	2.75e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TYMS—prostate cancer	2.47e-06	2.74e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NQO1—prostate cancer	2.46e-06	2.73e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—prostate cancer	2.44e-06	2.71e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.44e-06	2.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TH—prostate cancer	2.42e-06	2.69e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LPL—prostate cancer	2.4e-06	2.66e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—prostate cancer	2.36e-06	2.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.36e-06	2.61e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAV1—prostate cancer	2.35e-06	2.61e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—prostate cancer	2.34e-06	2.59e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAV1—prostate cancer	2.33e-06	2.58e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.33e-06	2.58e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.31e-06	2.57e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ERCC2—prostate cancer	2.3e-06	2.55e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GGT1—prostate cancer	2.28e-06	2.53e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA1—prostate cancer	2.25e-06	2.49e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.22e-06	2.47e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.22e-06	2.46e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—INS—prostate cancer	2.2e-06	2.44e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—prostate cancer	2.16e-06	2.39e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CREBBP—prostate cancer	2.16e-06	2.39e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.14e-06	2.37e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—RXRA—prostate cancer	2.14e-06	2.37e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.12e-06	2.35e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARA—prostate cancer	2.12e-06	2.35e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—COMT—prostate cancer	2.06e-06	2.29e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—prostate cancer	2.05e-06	2.27e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.05e-06	2.27e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—prostate cancer	2.04e-06	2.26e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—INS—prostate cancer	2.03e-06	2.25e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ITPR1—prostate cancer	2.02e-06	2.24e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—INS—prostate cancer	2.01e-06	2.23e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAV1—prostate cancer	1.99e-06	2.21e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CREBBP—prostate cancer	1.98e-06	2.2e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CREBBP—prostate cancer	1.97e-06	2.18e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—EP300—prostate cancer	1.94e-06	2.16e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NOS3—prostate cancer	1.93e-06	2.14e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TYMS—prostate cancer	1.91e-06	2.11e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.9e-06	2.11e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—prostate cancer	1.88e-06	2.09e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.88e-06	2.09e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.86e-06	2.07e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPL—prostate cancer	1.85e-06	2.05e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.81e-06	2.01e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.79e-06	1.98e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.78e-06	1.98e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NOS3—prostate cancer	1.78e-06	1.97e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ERCC2—prostate cancer	1.77e-06	1.97e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—prostate cancer	1.77e-06	1.96e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NOS3—prostate cancer	1.76e-06	1.95e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—INS—prostate cancer	1.72e-06	1.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CREBBP—prostate cancer	1.68e-06	1.86e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—prostate cancer	1.66e-06	1.85e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.64e-06	1.82e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARA—prostate cancer	1.63e-06	1.81e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.63e-06	1.8e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—prostate cancer	1.62e-06	1.8e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—prostate cancer	1.61e-06	1.79e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.59e-06	1.77e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—prostate cancer	1.54e-06	1.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAV1—prostate cancer	1.54e-06	1.7e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NOS3—prostate cancer	1.5e-06	1.67e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—EP300—prostate cancer	1.47e-06	1.63e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.44e-06	1.6e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—prostate cancer	1.42e-06	1.57e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—prostate cancer	1.4e-06	1.56e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.4e-06	1.55e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.39e-06	1.54e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—prostate cancer	1.38e-06	1.53e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—EP300—prostate cancer	1.35e-06	1.5e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—EP300—prostate cancer	1.34e-06	1.49e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—INS—prostate cancer	1.32e-06	1.47e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CREBBP—prostate cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—prostate cancer	1.2e-06	1.33e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—prostate cancer	1.17e-06	1.3e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NOS3—prostate cancer	1.16e-06	1.29e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—EP300—prostate cancer	1.14e-06	1.27e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.09e-06	1.21e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.07e-06	1.19e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—prostate cancer	1.06e-06	1.18e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.99e-07	1.11e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.91e-07	1.1e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—prostate cancer	9.26e-07	1.03e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—prostate cancer	8.88e-07	9.85e-06	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EP300—prostate cancer	8.83e-07	9.8e-06	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.47e-07	9.39e-06	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—prostate cancer	8.16e-07	9.06e-06	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—prostate cancer	8.09e-07	8.98e-06	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—prostate cancer	6.92e-07	7.67e-06	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.53e-07	7.25e-06	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—prostate cancer	5.34e-07	5.92e-06	CbGpPWpGaD
